JoelChasSchererMD

PubMed

• 44 citations
  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
  David Monteith, Emily C. Collins, Corinne Vandermeulen, Anne Van Hecken, Eyas Raddad, Joel C Scherer, David Grayzel, Thomas J Schuetz, Jan de Hoon> ;Frontiers in Pharmacology. 2017 Oct 17
• 41 citations
  A decade of innovation in pharmaceutical R&D: the Chorus model.
  Paul K. Owens, Eyas Raddad, Jeffrey W. Miller, John R. Stille, Kenneth G. Olovich, Neil Smith, Rosie S. Jones, Joel C Scherer> ;Nature Reviews. Drug Discovery. 2015 Jan 1
• 2 citations
  Site of effect of LY2951742 for migraine prophylaxis–Authors' reply
  David W. Dodick, Peter J. Goadsby, Egilius L.H. Spierings, Joel C Scherer, Steven Sweeney, David S Grayzel> ;The Lancet. Neurology. 2015 Jan 1
• 263 citations
  Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placeb...
  David W. Dodick, Peter J. Goadsby, Egilius L.H. Spierings, Joel C Scherer, Steven Sweeney, David S Grayzel> ;The Lancet. Neurology. 2014 Sep 1
• 137 citations
  Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 ...
  Joanne Sloan-Lancaster, Eyas Abu-Raddad, John Polzer, Jeffrey W. Miller, Joel C Scherer, Andrea De Gaetano, Jolene K. Berg, William H. Landschulz> ;Diabetes Care. 2013 Mar 20
• 26 citations
  Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.
  Elliott M. Antman, Howard A. Cooper, Charles Michael Gibson, J.A. de Lemos, Carolyn H. McCabe, Robert P. Giugliano, P Coussement, Sean P. Murphy, Joel C Scherer, Keave...> ;European Heart Journal. 2002 Jun 1
• 7 citations
  Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients
  Maureen J. Lage, Beth L. Barber, Patrick L. McCollam, Mohan V. Bala, Joel C Scherer> ;Catheterization and Cardiovascular Interventions. 2001 Jul 1
• 6 citations
  Impact of abciximab versus tirofiban on hospital length of stay for PCI patients
  Maureen J. Lage, Beth L. Barber, Patrick L. McCollam, Mohan V. Bala, Joel C Scherer> ;Catheterization and Cardiovascular Interventions. 2001 Mar 1
• 76 citations
  Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14
  Elliott M. Antman, C M Gibson, J.A. de Lemos, Robert P. Giugliano, Carolyn H. McCabe, P Coussement, Ian Menown, Christoph A. Nienaber, T.C Rehders, Martin J. Frey, R. ...> ;European Heart Journal. 2000 Dec 1
• 54 citations
  High Levels of Platelet Inhibition With Abciximab Despite Heightened Platelet Activation and Aggregation During Thrombolysis for Acute Myocardial Infarction Results Fr...
  Stephanie Coulter, Christopher P. Cannon, Kenneth A. Ault, Elliott M. Antman, Frans Van de Werf, A.A.Jennifer Adgey, C. Michael Gibson, Robert P. Giugliano, Mary Ann M...> ;Circulation. 2000 Jun 13
• 194 citations
  Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: Observations from the TIMI 14 trial
  James A. de Lemos, Elliott M. Antman, C. Michael Gibson, Carolyn H. McCabe, Robert P. Giugliano, Sabina A. Murphy, Stephanie Coulter, Keaven M. Anderson, Joel C Schere...> ;Circulation. 2000 Jan 25
• 517 citations
  Abciximab Facilitates the Rate and Extent of Thrombolysis Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 Trial
  Elliott M. Antman, Robert P. Giugliano, C. Michael Gibson, Carolyn H. McCabe, P Coussement, Neal S. Kleiman, Alec Vahanian, A.A.Jennifer Adgey, Ian B. A. Menown, Hans ...> ;Circulation. 1999 Jun 1
• Join now to see all

Journal Articles

• Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placeb...  
  David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel, Lancet Neurology, 8/11/2014